These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 21991841)
1. [Macrolides in antibiotic therapy of infections of the bronchial tree]. Płusa T Pol Merkur Lekarski; 2011 Sep; 31(183):139-44. PubMed ID: 21991841 [TBL] [Abstract][Full Text] [Related]
2. Macrolides and airway inflammation in children. Shinkai M; Rubin BK Paediatr Respir Rev; 2005 Sep; 6(3):227-35. PubMed ID: 16153572 [TBL] [Abstract][Full Text] [Related]
3. [Types and characteristics of macrolides]. Płusa T Pol Merkur Lekarski; 2008 Nov; 25(149):403-7. PubMed ID: 19177775 [TBL] [Abstract][Full Text] [Related]
4. Bacterial resistance in the new millennium. Its impact on antibiotic selection for respiratory tract infections. Appelbaum PC Postgrad Med; 2000 Dec; 108(7 Suppl Contemporaty):5-16. PubMed ID: 19667544 [TBL] [Abstract][Full Text] [Related]
5. Pro: antibiotics for chronic bronchitis with exacerbations. Isada CM Semin Respir Infect; 1993 Dec; 8(4):243-53. PubMed ID: 7938921 [TBL] [Abstract][Full Text] [Related]
6. Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients. Murray TS; Egan M; Kazmierczak BI Curr Opin Pediatr; 2007 Feb; 19(1):83-8. PubMed ID: 17224667 [TBL] [Abstract][Full Text] [Related]
7. [Clinical basis of macrolides apply in diseases of the respiratory tract]. Płusa T Pol Merkur Lekarski; 2008 Nov; 25(149):432-6. PubMed ID: 19177783 [TBL] [Abstract][Full Text] [Related]
8. [The role of macrolides in treatment of exacerbations of chronic obstructive pulmonary disease]. Targowski T; Jahnz-Rózyk K Pol Merkur Lekarski; 2010 Apr; 28(166):311-4. PubMed ID: 20491344 [TBL] [Abstract][Full Text] [Related]
13. Antibiotic use among children in British Columbia, Canada. Marra F; Patrick DM; Chong M; Bowie WR J Antimicrob Chemother; 2006 Oct; 58(4):830-9. PubMed ID: 16921182 [TBL] [Abstract][Full Text] [Related]
14. Activity of moxifloxacin on biofilms produced in vitro by bacterial pathogens involved in acute exacerbations of chronic bronchitis. Roveta S; Schito AM; Marchese A; Schito GC Int J Antimicrob Agents; 2007 Nov; 30(5):415-21. PubMed ID: 17768034 [TBL] [Abstract][Full Text] [Related]
16. Biofilms and antibiotic therapy: is there a role for combating bacterial resistance by the use of novel drug delivery systems? Smith AW Adv Drug Deliv Rev; 2005 Jul; 57(10):1539-50. PubMed ID: 15950314 [TBL] [Abstract][Full Text] [Related]
17. Population antibiotic susceptibility for Streptococcus pneumoniae and treatment outcomes in common respiratory tract infections. Furuno JP; Metlay JP; Harnett JP; Wilson J; Langenberg P; McGregor JC; Zhu J; Perencevich EN Pharmacoepidemiol Drug Saf; 2006 Jan; 15(1):1-9. PubMed ID: 16136615 [TBL] [Abstract][Full Text] [Related]
18. [The bacteriological study of bronchial secretions as a premise to rational therapy]. Curci G; Fabbrocini V Arch Monaldi; 1974; 29(3-4):309-13. PubMed ID: 4463915 [No Abstract] [Full Text] [Related]
19. Macrolide resistance rates in respiratory pathogens in Slovenia following reduced macrolide use. Cizman M; Beović B; Seme K; Paragi M; Strumbelj I; Müller-Premru M; Cad-Pecar S; Pokorn M Int J Antimicrob Agents; 2006 Dec; 28(6):537-42. PubMed ID: 17101264 [TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions? Amsden GW J Antimicrob Chemother; 2005 Jan; 55(1):10-21. PubMed ID: 15590715 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]